Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line TKIs
Ontology highlight
ABSTRACT: Via a GWA study, several SNPs have been identified as markers capable of predicting prognosis of lung cancer patients receiving TKIs therapy as first-line treatment. In order to get insights into how these genetic variants are linked to traits of interest, we conducted a genome-wide eQTL study by integrated analyses of SNP genotyping array data and gene expression array data of 115 subjects of lung adenocarcinoma. Our study successfully identified several SNPs as eQTLs, whose genotype were significantly associated with expression levels of several already known genes related to lung cancer.
ORGANISM(S): Homo sapiens
PROVIDER: GSE46539 | GEO | 2016/04/30
SECONDARY ACCESSION(S): PRJNA201404
REPOSITORIES: GEO
ACCESS DATA